Healthtech Startups
17,202 companies tagged Healthtech, with their investors and founders.
Kodiak Sciences develops biopharmaceutical therapies for chronic ophthalmic diseases, with a focus on patient outcomes and stakeholder impact in the healthcare system.
0 investors
0 investors
0 investors
0 investors
Koutif Therapeutics develops therapeutic compounds that inhibit the inflammatory cascade by targeting the ubiquitin degradation pathway, specifically using an inhibitor of the Fbxo3 E3 ligase to degrade pro-inflammatory proteins such as TRAFs and the NLRP3 inflammasome. Its drug discovery approach is based on intellectual property licensed from the University of Pittsburgh and the U.S. Department of Veterans Affairs, aimed at treating inflammatory conditions.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Kurin manufactures blood culture collection sets with contamination-reducing technology for healthcare providers. The company provides clinical support, data analytics, and outcomes measurement through proprietary platforms.
0 investors
Kuya operates holistic wellness spaces designed to support healing and personal growth, offering amenities such as sensory deprivation tanks, integration rooms, saunas, and cold plunge areas. It serves individuals seeking relaxation and health optimization in nature-inspired environments.
0 investors
0 investors
Kythera Labs builds data technology and analytics products for the healthcare and life sciences industries, focused on processing and analyzing large-scale healthcare and real-world data. Its platform supports market analysis, operational decision-making, and BioPharma research for healthcare organizations.
0 investors
0 investors
0 investors
Lactalogics develops human milk-based nutrition products for premature and at-risk infants, serving settings from the NICU to at-home care. It also operates a program connecting mothers with excess breast milk to babies in need.
0 investors
0 investors
0 investors
Lakewood Amedex develops antimicrobial compounds, specifically Bisphosphocin® formulations, designed as locally delivered bactericides and fungicides with potential medical applications. The company focuses on advancing antimicrobial technology to address infection treatment needs.
0 investors
0 investors
0 investors
0 investors
0 investors